secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001641172-25-021882
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma enters $130K convertible note financing with CFI Capital
------------------------------------------------------------------------

- Issued a 6% convertible promissory note for $130,000 principal; $13,000 original issue discount, net proceeds $117,000.
- Note matures July 28, 2026; interest payable in common stock at holder's option.
- Conversion price set at 60% of lowest trading price over prior 20 trading days on OTC Markets.
- Company reserved 15,700,485 common shares for conversion; holder must maintain 5x coverage reserve.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225021882/0001641172-25-021882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225021882/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer